More and more people are using companion robots to boost social connection, mental support, and overall health. The science suggests it’s more than a gimmick.
Anti-CD20 antibody therapy can be effectively and safely administered subcutaneously to patients with MS, even when switching from a prior treatment, two clinical trials suggest.